XJPX4360
Market cap31mUSD
Jan 09, Last price
630.00JPY
1D
-3.96%
1Q
23.29%
IPO
-10.26%
Name
MANAC Chemical Partners Co Ltd
Chart & Performance
P/E
61.25
P/S
0.52
EPS
10.29
Div Yield, %
2.39%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
9.69b
-18.28%
Net income
82m
-90.01%
CFO
-118m
L
Dividend
Mar 28, 20250 JPY/sh
Profile
MANAC Chemical Partners Co.,Ltd, together with its subsidiaries, engages in the development, manufacture, sale, import, and export of industrial chemicals and pharmaceuticals in Japan. It is also involved in the supply of raw materials, including flame retardants, antibacterial agents, veterinary drugs, food additives, photosensitive materials, and other materials to technological industries of various fields. In addition, the company provides warehouse leasing services. MANAC Chemical Partners Co.,Ltd was founded in 1948 and is based in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY |
|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | |
| Income | |||
Revenues | 9,686,000 -18.28% | 11,853,000 10.74% | 10,703,000 |
Cost of revenue | 8,636,000 | 9,705,000 | 8,872,000 |
Unusual Expense (Income) | |||
NOPBT | 1,050,000 | 2,148,000 | 1,831,000 |
NOPBT Margin | 10.84% | 18.12% | 17.11% |
Operating Taxes | (2,000) | 312,000 | 228,000 |
Tax Rate | 14.53% | 12.45% | |
NOPAT | 1,052,000 | 1,836,000 | 1,603,000 |
Net income | 82,000 -90.01% | 821,000 15.31% | 712,000 |
Dividends | (120,000) | (119,000) | (137,000) |
Dividend yield | 2.40% | 1.86% | 3.29% |
Proceeds from repurchase of equity | |||
BB yield | |||
| Debt | |||
Debt current | 290,000 | 291,000 | |
Long-term debt | |||
Deferred revenue | |||
Other long-term liabilities | 21,000 | 36,000 | 43,000 |
Net debt | (4,751,000) | (4,950,000) | (3,410,000) |
| Cash flow | |||
Cash from operating activities | (118,000) | 1,647,000 | 714,000 |
CAPEX | (475,000) | (250,000) | (684,000) |
Cash from investing activities | (231,000) | 199,000 | (422,000) |
Cash from financing activities | (75,000) | (125,000) | (200,000) |
FCF | 548,000 | 2,586,000 | |
| Balance | |||
Cash | 3,286,000 | 3,721,000 | 2,044,000 |
Long term investments | 1,465,000 | 1,519,000 | 1,657,000 |
Excess cash | 4,266,700 | 4,647,350 | 3,165,850 |
Stockholders' equity | 8,214,000 | 8,054,000 | 7,344,000 |
Invested Capital | 7,003,300 | 6,506,650 | 7,424,150 |
ROIC | 15.57% | 26.36% | 21.59% |
ROCE | 9.21% | 19.18% | 17.21% |
| EV | |||
Common stock shares outstanding | 8,016 | 7,953 | 7,874 |
Price | 625.00 -22.17% | 803.00 51.80% | 529.00 |
Market cap | 5,010,080 -21.55% | 6,386,383 53.33% | 4,165,197 |
EV | 259,080 | 1,436,383 | 755,197 |
EBITDA | 1,513,000 | 2,634,000 | 2,281,000 |
EV/EBITDA | 0.17 | 0.55 | 0.33 |
Interest | 1,000 | 1,000 | 1,000 |
Interest/NOPBT | 0.10% | 0.05% | 0.05% |